Juries across the country have been handing down “eye catching” verdicts for plaintiffs with ovarian cancer and their families against Johnson & Johnson. The most recent included a nearly $4.7 billion verdict for

Philadelphia Court of Common Pleas Judge Paula Patrick urges the Pennsylvania Superior Court to uphold the $70 Million jury verdict in A.Y. v. Janssen Pharmaceuticals. AY is one of many boys who developed

As the nation’s opioid crisis continues 162 of the 600 people recently charged with healthcare fraud were healthcare professionals who contributed to the nation’s fastest and most deadly epidemic. Conducted nationwide, this was the largest

Super Lawyers has again recognized the attorneys of Sheller P.C. in 2018. Founder Stephen A. Sheller has been selected by the organization for the fifteenth consecutive year. Attorneys Kimberly A. Aponte Borden and Jamie

Sheller PC’s founder, Stephen Sheller, joined other litigators, judges and state prosecutors at a conference to discuss the legal response to the opioid crisis. The forum was hosted by University of Pennsylvania Law

Stephen A. Sheller, who has served on the board of trustees of Drexel University since 2003 and on Drexel’s Thomas R. Kline School of Law advisory board, will receive an honorary degree at

More than 100 states, cities, counties and other public entities have filed opioid-related lawsuits against the drug manufacturers in 2017. The lawsuits being filed continue into 2018 including the city of Philadelphia who

Sheller PC is one of five private law firms assisting the city of Philadelphia’s Law Department in its suit against pharmaceutical companies attempting to hold them accountable for the current opioid crisis. Five

In a significant ruling by the Pennsylvania Superior Court, Janssen, a subsidiary of Johnson & Johnson (J&J), will now face punitive damages in Risperdal mass tort suits. A previous Philadelphia trial court ruling

A Philadelphia jury awarded Lynn Hartman $27.8 million after finding drug manufacturers Johnson & Johnson and Bayer failed to warn about the dangers of their blood thinning drug Xarelto. The verdict includes $26